Work

Abstract A008: ERBB2 activating mutations define a delivery-permissive state enhancing trastuzumab deruxtecan activity in HER2-non-amplified breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.d32026-a008

Authors: Sharanya Nag, Bo Liu, Wanyi Chen, Avantika Gupta, Sarat Chandarlapaty, Joshua Z. Drago, Nicholas Mai

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7169851959

Cites:

Cited by:

Related to: 10